Does Your Insurance Cover a Sleep Apnea Implant?
Check your insurance carrier and clinical information to see a personalized estimate of whether you may meet coverage criteria for Inspire therapy.
How This Tool Works
This screening tool checks your insurance carrier's published coverage criteria against your clinical information. It draws from over 90 payer policies — including Medicare, Medicare Advantage, and major commercial insurers — so you can see what your plan typically requires before your first appointment.
This is an educational aid, not a coverage determination. Your physician's office will verify your specific plan details during the prior authorization process.
Insurance Coverage for Inspire Therapy: What You Need to Know
Most major insurance carriers now cover Inspire upper airway stimulation therapy for obstructive sleep apnea, but coverage criteria vary significantly between plans. Medicare, UnitedHealthcare, Aetna, Blue Cross Blue Shield plans, Cigna, Humana, and many others each maintain their own published medical policies with different thresholds for AHI, BMI, sleep study requirements, and documentation standards.
Medicare has specific rules. Traditional Medicare (fee-for-service) requires a BMI under 35, an AHI between 15 and 65 scored using the CMS 4% desaturation criteria, documented CPAP intolerance, a drug-induced sleep endoscopy (DISE) showing no complete concentric collapse at the palate, and no anatomical findings that would compromise the device. Medicare Advantage plans generally follow similar criteria but may have slight variations.
Commercial insurance is generally more flexible. Many commercial payers follow the broader FDA indication, which allows an AHI of 15 to 100 and a BMI up to 40. However, nearly all carriers require documented CPAP failure or intolerance, and many still require an in-lab sleep study rather than a home sleep test.
| Criteria | Commercial Plans (typical) | Medicare |
|---|---|---|
| AHI range | 15 – 100 | 15 – 65 |
| BMI limit | ≤ 40 | < 35 |
| Central apneas | < 25% of total AHI | < 25% of total AHI |
| Sleep study | In-lab PSG (most plans) | In-lab PSG |
| Study recency | Within 2 years (most) | Within 2 years |
| CPAP trial | Required | Required |
| DISE required | Not always | Yes — no complete concentric collapse |
Prior authorization is almost always required. Your surgeon's office typically handles this process, submitting your sleep study results, CPAP trial documentation, and DISE findings to your carrier. Understanding what your specific plan requires — which is what this tool helps you do — means you can arrive at your consultation with the right records already in hand.
The total cost context. The total procedure cost typically ranges from $30,000 to $65,000. Most patients with insurance pay significantly less out of pocket. Medicare Part B covers 80% after the annual deductible. Commercial plan out-of-pocket costs depend on your specific deductible and coinsurance structure.
Frequently Asked Questions
Yes. Medicare covers Inspire under specific criteria: AHI between 15 and 65 (scored with CMS 4% desaturation criteria), BMI under 35, documented CPAP intolerance, and a DISE showing no complete concentric collapse at the velum. The sleep study must be an in-lab polysomnography. Medicare Part B typically pays 80% of the approved amount after your annual deductible.
Total procedure costs range from $30,000 to $65,000. With insurance, most patients pay their plan's surgical copay or coinsurance. Medicare patients typically pay 20% of the approved amount. Your exact out-of-pocket cost depends on your deductible, coinsurance rate, and whether you have met your out-of-pocket maximum for the year.
United Healthcare covers Inspire for patients who meet their medical policy criteria, which generally includes documented CPAP intolerance, an appropriate AHI range, and BMI within their threshold. Pre-authorization is required. Specific criteria may vary by plan type — use the tool above to check UHC's published requirements against your clinical information.
Prior authorization is your insurance company's advance approval before surgery. Your surgeon's office submits clinical documentation — sleep study results, CPAP trial records, and DISE findings — to demonstrate you meet your carrier's coverage criteria. This process typically takes one to four weeks and is a standard part of the surgical scheduling timeline.
Denials can often be appealed successfully. Common reasons include incomplete documentation, a sleep study that does not meet the carrier's specific scoring criteria, or a BMI slightly above the threshold. Your surgeon's office can help with the appeal process, which may include submitting additional records or requesting a peer-to-peer review with the insurance medical director.
Genio received FDA approval in August 2025 and CMS finalized 2026 reimbursement rates for the procedure. Medicare coverage is now available. Commercial insurance coverage is still developing, with some carriers beginning to publish formal coverage policies. Check with your specific carrier for current Genio coverage status. This tool currently focuses on Inspire criteria.